Introduction
============

Oral neutropenic ulcerations have been so far described in patients suffering from neutropenia, multiple myeloma, and acute as well as T-large cell leukemia ([@r1]-[@r4]). Barrett and Buckley ([@r2]) report that neutropenic ulceration and herpes simplex infection were the major causes of morbidity in three patients following administration of high-dose melphalan for the treatment of multiple myeloma. In 2000, Copete and Sheridan ([@r3]) concluded that it was still unclear whether ulcerations in the oral cavity of patients undergoing leukemia treatment were caused by infective etiology or they were manifestations of neutropenia. The same was concluded by Arvanitidou *et al*. ([@r4]) in 2011. It seems that the degree of susceptibility to infection is roughly proportional to the blood neutrophil count.

However, it seems that oral ulcerations in leukemic patients might be a result of the following: 1) oral ulcerations might be induced by neutropenia in leukemic patients; 2) oral ulcerations may be a side effect of cytotoxic chemotherapy or develop as a consequence of direct toxicity of the medication itself. It is well known that chemotherapy agents such as methotrexate might induce oral ulcerations and that these might be dose dependent. It is well recognized that patients may benefit from temporary discontinuation of methotrexate ([@r4]); and 3) infectious etiology of oral ulcerations.

In the literature published so far, there have been few case reports on bacterial species such as oral *Fusarium moniliforme* ([@r5]), *Capnocytophaga ochracea* and *sputigena* ([@r6], [@r7]), *Leptotrichia trevisanii* ([@r8]), and *Streptococcus mitis* ([@r9]) infection which manifested as necrotic gingival ulceration in granulocytopenic patients. Furthermore, there also are case reports on viral infection such as herpes simplex virus ([@r10], [@r11]), Epstein-Barr virus ([@r12]), cytomegalovirus ([@r13]) in the oral cavity in patients undergoing chemotherapy for hematologic malignancies. The last but not the least, fungal infections such as candidiasis ([@r14]), aspergillosis ([@r15]), mucormycosis ([@r16]) and histoplasmosis ([@r17]) might be encountered in these patients.

Barrett *et al*. ([@r18]) report that oral complications were detected in 89% of hospital admissions for treatment of acute leukemia in adults. Changes that reflected the underlying myelosuppression and general immunosuppression predominated. Hemorrhagic phenomena (77%), neutropenic ulceration (49%), and herpes simplex virus infections (39%) were the most common ones. Beattie *et al*. ([@r19]) report that mouth ulcers are a frequent cause of morbidity in patients rendered neutropenic as a result of chemotherapy. The same authors ([@r19]) report that herpes simplex virus (type I) was isolated in 13 patients and *Candida albicans* cultured in 17 patients. Both organisms were isolated in 9 patients. Their results suggest that both viral and fungal elements may be important in the etiology of oral ulceration and that antiviral and antifungal agents may each have a role in the prophylaxis and treatment of such patients.

Case Report
===========

A 40-year-old female patient was referred to the Department of Oral Medicine due to painful oral lesions. Clinical examination revealed oral ulceration on the vestibular mucosa above teeth 21, 22, 25 and 26, which were 1 cm in diameter. There was also oral ulceration 3 mm in diameter behind tooth 46 in the retromolar area and on the tongue. Tooth 46 was implant supported crown. All ulcerations were covered with thick pseudomembranes and minimal surrounding inflammation. According to the orthopantomogram and vitality tests of the teeth, we concluded that ulcerations were of non-odontogenic origin. No plaque deposits on the teeth could be noticed ([Fig 1](#f1){ref-type="fig"}, [Fig 2](#f2){ref-type="fig"}).

![Neutropenic ulceration on the gingiva above teeth 24, 25 and 26.](acc-58-556-f1){#f1}
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Ten months before her referral to the specialist in oral medicine, the patient was diagnosed with diffuse large B-cell lymphoma, stage IVA. She received five cycles of chemotherapy according to the R-CHOEP protocol (rituximab, cyclophosphamide, doxorubicin, vincristine, methylprednisolone and etoposide), followed by three cycles of R-CHEVP (rituximab, cyclophosphamide, doxorubicin, etoposide, vinblastin and methylprednisolone) due to toxic neuropathy. Complete remission of lymphoma was achieved, but the clinical course was further complicated by the development of dilated cardiomyopathy two months after completion of hematologic treatment. In addition, prolonged thrombocytopenia was observed during the last two cycles of R-CHEVP and five months after initiating the treatment, bone marrow aspirate was examined due to pancytopenia. While the myleogram showed no abnormalities, 10% myeloblasts were found by immunophenotyping and monosomy of chromosomes 5 and 7 by cytogenetics. On repeated bone marrow examination two weeks later, myelogram showed 13% myeloblasts and the finding was classified as refractory anemia with excess blasts-2 (RAEB-2). Since RAEB developed after chemotherapy treatment, it was considered to be treatment-related. The patient received supportive therapy, mainly platelet transfusions and antimicrobial prophylaxis, and also a short course of thioguanine which led to severe neutropenia. Seven months after starting chemotherapy treatment, the bone marrow finding progressed to acute myeloid leukemia with 40% blasts. Due to severe cardiomyopathy, the patient was unsuitable for intensive chemotherapy and was treated with three cycles of azacitidine during which time she also received antimicrobial prophylaxis with ciprofloxacin, acyclovir and fluconazole. After completion of the first cycle of azacitidine, the patient developed oral ulcerations for which she was referred to the Department of Oral Medicine.

Upon referral to the Department of Oral Medicine, her blood tests showed pancytopenia with leukocytes 0.9 (x10^9^) (normal range 3.4-9.7), red blood cells 3.38 (x10^12^) (4.34-5.72), hemoglobin 99 (g/L) (138-175), mean corpuscular volume 88 (fL) (83-97.2), and platelets 29 (x10^9^/L) (158-424). The patient was taking Lanitop (methyldigoxin), Fursemid (furosemide), Tritace (ramipril), Aldactone (spironolactone), Carvelol (cervedilol), Controloc (pantoprazole), Diflucan (fluconazole), Ciprofloxacin (ciprofloxacin).

In order to alleviate pain and oral ulcerations, she was advised to take mouthwash three times a day (Curasept, Curaprox, 0.05%), Dolokain gel (lidocaine), Gelclair (Helsinn Healthcare SA, Lugano, Switzerland), Diflamm solution (benzydamine hydrochloride, 3M), and betamethasone (Beloderm, Belupo, Koprivnica, Croatia) in orabase.

Unfortunately, throughout azacitidine treatment, the patient had severe neutropenia and eventually died from infectious complications, i.e. *Staphylococcus hominis* sepsis and *Aspergillus flavus* rhinosinusitis.

Discussion
==========

In our patient, oral fungal and viral swabs were all negative upon admission, therefore we concluded that ulcerations were exclusively due to neutropenia. Biopsy specimen was not obtained as the patient was severely thrombocytopenic and received blood transfusion almost every other day.

Several days before the patient died, oral microbial tests had shown the presence of *Stenotrophomonas maltophilia* and *Enterobacterium foecalis. Stenotrophomonas maltophilia* is an anaerobic gram-negative bacillus found in aquatic environments. It is an opportunistic microorganism of low virulence. *Stenotrophomonas maltophilia* causes infection in immunosuppressed hosts, especially those with neutropenia, on chemotherapy and broad-spectrum antibiotics ([@r20]). To our knowledge, there are only two case reports on exclusive *Stenotrophomonas maltophilia* infection in the oral cavity. Miyairi *et al*. ([@r21]) described an immunocompromised patient with acute ulcerative necrotic gingivitis and bacteremia due to *Stenotrophomonas maltophilia*. Soga *et al*. ([@r22]) described a patient with appearance of multidrug-resistant *Stenotrophomonas maltophilia* on the gingiva during leukemia treatment.

Based on our case, it seems that detection of *Stenotrophomonas maltophilia* and *Enterobacterium foecalis* was a concomitant finding in the oral cavity as neutropenic ulcers had been present for three months before these bacteria were found. However, we do agree with Teo *et al*. ([@r20]) that the finding of mucocutaneous infections in neutropenic patients with malignancies seem to be a poor prognostic sign.

Differential diagnoses of ulcerations in neutropenic patients might be acute necrotizing ulcerative gingivitis, leukemic infiltrates, ulcers induced as a direct consequence of chemotherapy, bacterial, viral or fungal infection ([@r23]).

In patients undergoing leukemia treatment, gingiva acts as a site of proliferation and reservoir of multidrug-resistant opportunistic bacteria. To prevent abnormal increases in such bacteria on the gingiva, scaling and/or root planing together with local antiseptic and local/systemic antibiotic may contribute to infection control in such patients. This is sometimes impossible as patients may have severe neutropenia or thrombocytopenia, as seen in our case, as well as in cases reported by Arvanitidou *et al*. ([@r4]).

In most cases, neutropenic ulcerations will clear up as the neutrophil count returns to normal values. However, it was not the case in our patient as the patient died.

Conclusion
==========

Prolonged neutropenia, as in this case of a patient with therapy-related myelodysplastic syndrome/therapy-related acute myeloid leukemia, was the underlying cause of oral ulcers rather than chemotherapy. In our patient, the presence of *Stenotrophomonas maltophilia* was considered as colonization. The last but not the least, all oral therapeutic procedures failed to improve oral ulcerations in our patient.
